Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
29 IorgaA.DaraL.KaplowitzN
Ruxolitinib cream is currently the first Food and Drug Administration (FDA) approved vitiligo therapy for the topical treatment of non-segmental vitiligo in adults and pediatric patients over 12 years of age (119)
The stigma aimed at the severely obese has not ebbed in our society despite the majoritys significant weight gain
The patent discloses a total of 514 specific compounds
Separation and detection methods for covalent drug-protein adducts
Referncias: 1- Literatura do Fornecedor
US$ 25.95
US$ 28.48
US$ 29.53
US$ 29.73
US$ 20.01
US$ 25.35
US$ 26.29
US$ 21.30
US$ 22.80
